BioRay Filed IND Application for BRY812, a Novel Antibody Drug Conjugate Targeting LIV-1 ...Middle East

SHANGHAI, May 24, 2023 /PRNewswire/ -- BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as BioRay) announced that the Investigational New Drug (IND) application for the clinical trial of its proprietary BRY812, a novel antibody-drug conjugate (ADC) targeting human LIV-1 for the...

Hence then, the article about bioray filed ind application for bry812 a novel antibody drug conjugate targeting liv 1 was published today ( Wednesday 24/05/2023 - 11:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BioRay Filed IND Application for BRY812, a Novel Antibody Drug Conjugate Targeting LIV-1 )

Also on site :

• Gwyneth Paltrow Reveals Famous Ex-Boyfriend Introduced Her to Robin Williams Years After Their First Movie Together
• Zelensky’s ex-deputy chief of staff charged with ‘green’ energy scam
• The 50 Best 'Survivor' Challenges Ever — According to the People Who Made Them (Exclusive)